Docking study: PPARs interaction with the selected alternative plasticizers to di(2-ethylhexyl) phthalate

References

• Lowell Center for Sustainable Production. Phthalates and their Alternatives: Health and Environmental Concerns (2011). Available from: http://www.sustainableproduction.org/publ.alternatives.php [last accessed Sept 2014]
   Google Scholar
• Wargo J, Cullen MR, Taylor HS. Plastics that may be harmful to children and reproductive health. Environment & Human Health, Inc. (EHHI); 2008. Available from: www.ehhi.org/reports/plastics/ehhi_plastics_report_2008.pdf [last accessed Aug 2014]
   Google Scholar
• Heudorf U, Mersch-Sundermann V, Angerer J. Phthalates: toxicology and exposure. Int J Hyg Env Health 2007;210:623–34
   PubMed Web of Science ®Google Scholar
• Bagel S, Decaudin B, Neuville S, et al. Phthalates in medical devices for parenteral and enteral nutrition. Nutr Clin Met 2011;25:15–23
   Web of Science ®Google Scholar
• Kambia N, Dine T, Gressier B, et al. Strong variability of di(2-ethylhexyl)phthalate (DEHP) plasmatic rate in infants and children undergoing 12-hour cyclic parenteral nutrition. J Parenter Enteral Nutr 2013;37:229–35
   PubMed Web of Science ®Google Scholar
• Mankidy R, Wiseman S, Ma H, Giesy JP. Biological impact of phthalates. Toxicol Lett 2013;217:50–8
   PubMed Web of Science ®Google Scholar
• Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). Preliminary Report on the Safety of Medical Devices Containing DEHP Plasticized PVC or Other Plasticizers on Neonates and Other Groups Possibly at Risk. European Commission Health and Consumer Protection Directorate-General 2007. Available from: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_008.pdf [last accessed July 2014]
   Google Scholar
• Newbold RR. Impact of environmental endocrine disrupting chemicals on the development of obesity. Hormones 2010;9:206–17
   PubMedGoogle Scholar
• Goncharov A, Haase RF, Santiago-Rivera A, et al. High serum PCBs are associated with elevation of serum lipids and cardiovascular disease in a native American population. Environ Res 2008;106:226–39
   PubMed Web of Science ®Google Scholar
• Schug TT, Janesick A, Blumberg B, Heindel JJ. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 2011;127:204–15
   PubMed Web of Science ®Google Scholar
• Newbold RR, Padilla-Banks E, Jefferson WN, Heindel JJ. Effects of endocrine disruptors on obesity. Int J Androl 2008;31:201–8
   PubMed Web of Science ®Google Scholar
• Tremblay A, Chaput JP. About unsuspected potential determinants of obesity. Appl Physiol Nutr Metab 2008;33:791–6
   PubMed Web of Science ®Google Scholar
• Desvergne B, Feige JN, Casals-Casas C. PPAR-mediated activity of phthalates: a link to the obesity epidemic? Mol Cell Endocrinol 2009;304:43–8
   PubMed Web of Science ®Google Scholar
• U.S. Environmental Protection Agency. Phthalates Action Plan (Revised 03/14/2012). Available from: http://www.epa.gov/oppt/existingchemicals/pubs/actionplans/phthalates_ actionplan_revised_2012-03-14.pdf [last accessed Jul 2014]
   Google Scholar
• Genay S, Luciani C, Décaudin B, et al. Experimental study on infusion devices containing polyvinyl chloride: to what extent are they di(2-ethylhexyl)phthalate-free? Int J Pharm 2011;412:47–51
   PubMed Web of Science ®Google Scholar
• Directive, 2007/47/EC of the European parliament and of the Council of 5 September 2007 amending Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, Council Directive 93/42/EEC concerning medical devices and Directive 98/8/EC concerning the placing of biocidal products on the market (OJEU 21.09.2007)
   Google Scholar
• Barrett JR. To each his own: DEHP yields species-specific metabolic phenotypes. Environ Health Perspect 2010;118:A81
   PubMed Web of Science ®Google Scholar
• Babich MA. Review of exposure and toxicity data for phthalate substitutes (2010). Available from: http://www.cpsc.gov/PageFiles/126546/phthalsub.pdf [last accessed Jul 2014]
   Google Scholar
• Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res 2000;28:235–42
   PubMed Web of Science ®Google Scholar
• Cronet P, Petersen JFW, Folner R, et al. Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family. Structure 2001;9:699–706
   PubMed Web of Science ®Google Scholar
• Jones G, Willett P, Glen RC, et al. Development and validation of a genetic algorithm for flexible docking. J Mol Biol 1997;267:727–48
   PubMed Web of Science ®Google Scholar
• Kambia N, Renault N, Dilly S, et al. Molecular modelling of phthalates-PPARs interactions. J Enzyme Inhib Med Chem 2008;23:611–16
   PubMed Web of Science ®Google Scholar
• Ostberg T, Svensson S, Selén G, et al. A new class of peroxisome proliferator-activated receptor agonists with a novel binding epitope shows antidiabetic effects. J Biol Chem 2004;279:41124–30
   PubMed Web of Science ®Google Scholar
• Ito Y, Nakamura T, Yanagiba Y, et al. Plasticizers may activate human hepatic Peroxisome Proliferator-Activated Receptor a less than that of a mouse but may activate constitutive androstane receptor in liver. PPAR Res 2012;2012:201284
   PubMed Web of Science ®Google Scholar
• European Union, Directive 2005/84/EC of the European Parliament and of the Council of 14 December 2005 amending for the 22nd time Council Directive 76/769/EEC on the approximation of the Laws, Regulations and Administrative Provisions of the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations (phthalates in toys and childcare articles), 2005
   Google Scholar
• Janssen PJCM, Bremmer HJ. Risk assessment non-phthalate plasticizers in toys. 2009. Available from: https://www.vwa.nl/txmpub/files/?p_file_id=2000547.pdf [last accessed Jul 2014]
   Google Scholar
• Bernard L, Décaudin B, Lecoeur M, et al. Analytical methods for the determination of DEHP plasticizer alternatives present in medical devices: a review. Talanta 2014;129:39–54
   PubMed Web of Science ®Google Scholar
• Takeshita A, Igarashi-Migitaka J, Nishiyama K, et al. Acetyl tributyl citrate, the most widely used phthalate substitute plasticizer, induces cytochrome p450 3a through steroid and xenobiotic receptor. Toxicol Sci 2011;123:460–70
   PubMed Web of Science ®Google Scholar
• Gimeno P, Thomas S, Bousquet C, et al. Identification and quantification of 14 phthalates and 5 non-phthalate plasticizers in PVC medical devices by GC-MS. J Chromatogr B Analyt Technol Biomed Life Sci 2014;949–950:99–108
   PubMed Web of Science ®Google Scholar
• Chiellini F, Ferri M, Morelli A, et al. Perspectives on alternatives to phthalate plasticized poly(vinyl chloride) in medical devices applications. Prog Polym Sci 2013;38:1067–88
   Web of Science ®Google Scholar